Drug Information
| Drug General Information | |||||
|---|---|---|---|---|---|
| Drug ID |
D04QXM
|
||||
| Former ID |
DNC012689
|
||||
| Drug Name |
Tyr-D-Ala-Phe-Asp-Val-Val-Thr[Beta-D-Glc]-Gly-NH2
|
||||
| Indication | Discovery agent | Investigative | [534460] | ||
| Structure |
|
Download2D MOL |
|||
| Formula |
C47H69N9O17
|
||||
| Canonical SMILES |
CC(C)C(C(=O)NC(C(C)C)C(=O)NC(C(C)OC1C(C(C(C(O1)CO)O)O)O<br />)C(=O)NCC(=O)N)NC(=O)C(CC(=O)O)NC(=O)C(CC2=CC=CC=C2)NC(<br />=O)C(C)NC(=O)C(CC3=CC=C(C=C3)O)N
|
||||
| InChI |
1S/C47H69N9O17/c1-21(2)34(45(70)55-35(22(3)4)46(71)56-36(44(69)50-19-32(49)59)24(6)72-47-39(64)38(63)37(62)31(20-57)73-47)54-43(68)30(18-33(60)61)53-42(67)29(17-25-10-8-7-9-11-25)52-40(65)23(5)51-41(66)28(48)16-26-12-14-27(58)15-13-26/h7-15,21-24,28-31,34-39,47,57-58,62-64H,16-20,48H2,1-6H3,(H2,49,59)(H,50,69)(H,51,66)(H,52,65)(H,53,67)(H,54,68)(H,55,70)(H,56,71)(H,60,61)/t23-,24-,28+,29+,30+,31?,34+,35+,36+,37?,38?,39?,47?/m1/s1
|
||||
| InChIKey |
QTEVIWGWCOWBNP-KDWZCUTISA-N
|
||||
| PubChem Compound ID | |||||
| Target and Pathway | |||||
| Target(s) | Mu-type opioid receptor | Target Info | Inhibitor | [534460] | |
| Delta-type opioid receptor | Target Info | Inhibitor | [534460] | ||
| NetPath Pathway | TCR Signaling Pathway | ||||
| PANTHER Pathway | Heterotrimeric G-protein signaling pathway-Gi alpha and Gs alpha mediated pathway | ||||
| Heterotrimeric G-protein signaling pathway-Gq alpha and Go alpha mediated pathway | |||||
| Enkephalin releaseP00026:Heterotrimeric G-protein signaling pathway-Gi alpha and Gs alpha mediated pathway | |||||
| Enkephalin release | |||||
| Opioid proenkephalin pathway | |||||
| Opioid proopiomelanocortin pathway | |||||
| Pathway Interaction Database | IL4-mediated signaling events | ||||
| References | |||||
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.